Session 7: Public Accountability Around Disclosure and Where Are We Heading?
Merete Joergensen, MBA, MSc
Clinical Disclosure and Transparency Expert, Former EFPIA, CREG Clinical Trials
Merete-J Consulting CVR: 34920818, Denmark
New initiatives on how to improve, enforce and measure Data Sharing activities are being implemented and published. How are these measured? What has the impact been? How have organisations worked with these new initiatives? Future transparency ambitions, and how can we even get more out of these new initiatives?
British Medical Journal, United Kingdom
Making Publications, Disclosure and Data Sharing Commitments Go Hand in Hand: Lise Baltzer
Director for Global Publications
Novo Nordisk, Denmark
Data sharing the new initiative under the Good Pharma Score Card: Jennifer Miller, PhD
Associate Professor of Medicine; Co-Director, Program for Biomedical Ethics
Yale School of Medicine, United States
FDAAA TrialsTracker and the COMPare Trials project: Ben Goldacre
Senior Clinical Research Fellow, CEBM, Department of Primary Care Health Science
University of Oxford, United Kingdom
Have an account?